Existing regulations and safety-substantiation principles, as laid out by federal food and drug law and past FDA communications to industry, are adequate to support the safe marketing of cosmetics containing nanomaterials, the agency concludes in final guidance published June 24.
“We consider the current framework for safety assessment sufficiently robust and flexible to be appropriate for a variety of materials, including products containing nanomaterials,” FDA states.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?